The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Losartan Rowa 50mg film-coated tablets



Rowa Pharmaceuticals LimitedPA0074/082/002

Main Information

Trade NameLosartan Rowa 50mg film-coated tablets
Active SubstancesLosartan potassium
Dosage FormFilm-coated tablet
Licence HolderRowa Pharmaceuticals Limited
Licence NumberPA0074/082/002

Group Information

ATC CodeC09CA Angiotensin II antagonists, plain
C09CA01 losartan

Status

License statusAuthorised
Licence Issued05/06/2020
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version

Generics Information

Interchangeable List CodeIC0003-023-003
Interchangeable List DocumentPDF of Interchangeable List
« Back